Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00010803 · ClinicalTrials.gov registry record · Phase 3

Ginkgo Biloba Prevention Trial in Older Individuals

A Phase 3 study of Dementia and Alzheimers Disease, sponsored by National Center for Complementary and Integrative Health (NCCIH).

Completed
Registry status
Phase 3
Development phase
3,069
Enrollment target
5
Study locations

NCT00010803 is a Phase 3 study of Dementia and Alzheimers Disease that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 3,069 participants, below the 7,708-participant average among 199 other Dementia trials with a reported enrollment target (60% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00010803, a Phase 3 study of Dementia and Alzheimers Disease, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).

COMPLETED
Registry status
Phase 3
Development phase
3,069 participants
Enrollment target
5
Study locations

Study Summary

This study will determine the effect of 240mg/day Ginkgo biloba in decreasing the incidence of dementia and specifically Alzheimer's disease (AD), slowing cognitive decline and functional disability, reducing incidence of cardiovascular disease, and decreasing total mortality.

Conditions Studied

Dementia Alzheimers Disease

Interventions

  • DRUG Placebo
  • DRUG Ginkgo biloba

Study Locations (5)

California

  • University of California, Davis - Sacramento

Maryland

  • Johns Hopkins University - Baltimore

North Carolina

  • Wake Forest University School of Medicine - Winston-Salem

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Virginia

  • University of Pittsburgh/University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 3,069 participants
Start Date 2000-10
Est. Completion 2011-07
Phase Phase 3

Sponsor

National Center for Complementary and Integrative Health (NCCIH)

203 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00010803

The ClinicalTrials.gov registry entry for NCT00010803 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 3,069 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,708-participant average among 199 other Dementia trials with a reported enrollment target (60% lower). The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00010803 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Maryland, North Carolina.

Frequently Asked Questions

What is clinical trial NCT00010803 about?

NCT00010803 is a clinical study titled "Ginkgo Biloba Prevention Trial in Older Individuals". This study will determine the effect of 240mg/day Ginkgo biloba in decreasing the incidence of dementia and specifically Alzheimer's disease (AD), slowing cognitive decline and functional disability, reducing incidence of cardiovascular disease, and decreasing total mortality.

What is the current status of trial NCT00010803?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,069 participants. The study started on 2000-10. Estimated completion is 2011-07.

What conditions does trial NCT00010803 study?

This clinical trial studies the following conditions: Dementia, Alzheimers Disease.

What interventions are being tested in trial NCT00010803?

The interventions under investigation include: Placebo (DRUG), Ginkgo biloba (DRUG).

Who is sponsoring clinical trial NCT00010803?

This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00010803 being conducted?

This trial has 5 study locations across California, Maryland, North Carolina, Pennsylvania, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dementia

All registered trials for this condition

Alzheimers Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.